Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

Manuela Marron; Paolo Boffetta; Zuo Feng Zhang; David Zaridze; Victor Wünsch-Filho; Deborah M. Winn; Qingyi Wei; Renato Talamini; Neonila Szeszenia-Dabrowska; Erich M. Sturgis; Elaine Smith; Stephen M. Schwartz; Peter Rudnai; Mark P. Purdue; Andrew F. Olshan; Jose Eluf-Neto; Joshua Muscat; Hal Morgenstern; Ana Menezes; Michael McClean; Elena Matos; Ioan Nicolae Mates; Jolanta Lissowska; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Sergio Koifman; Karl Kelsey; Rolando Herrero; Richard B. Hayes; Silvia Franceschi; Leticia Fernandez; Eleonora Fabianova; Alexander W. Daudt; Luigino Dal Maso; Maria Paula Curado; Gabriella Cadoni; Chu Chen; Xavier Castellsague; Stefania Boccia; Simone Benhamou; Gilles Ferro; Julien Berthiller; Paul Brennan; Henrik Møller; Mia Hashibe

doi:10.1093/ije/dyp291

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

Manuela Marron, Paolo Boffetta, Zuo Feng Zhang, David Zaridze, Victor Wünsch-Filho, Deborah M. Winn, Qingyi Wei, Renato Talamini, Neonila Szeszenia-Dabrowska, Erich M. Sturgis, Elaine Smith, Stephen M. Schwartz, Peter Rudnai, Mark P. Purdue, Andrew F. Olshan, Jose Eluf-Neto, Joshua Muscat, Hal Morgenstern, Ana Menezes, Michael McCleanElena Matos, Ioan Nicolae Mates, Jolanta Lissowska, Fabio Levi, Philip Lazarus, Carlo La Vecchia, Sergio Koifman, Karl Kelsey, Rolando Herrero, Richard B. Hayes, Silvia Franceschi, Leticia Fernandez, Eleonora Fabianova, Alexander W. Daudt, Luigino Dal Maso, Maria Paula Curado, Gabriella Cadoni, Chu Chen, Xavier Castellsague, Stefania Boccia, Simone Benhamou, Gilles Ferro, Julien Berthiller, Paul Brennan, Henrik Møller, Mia Hashibe

Research output: Contribution to journal › Article › peer-review

195 Scopus citations

Abstract

Background: Quitting tobacco or alcohol use has been reported to reduce the head and neck cancer risk in previous studies. However, it is unclear how many years must pass following cessation of these habits before the risk is reduced, and whether the risk ultimately declines to the level of never smokers or never drinkers. Methods: We pooled individual-level data from case-control studies in the International Head and Neck Cancer Epidemiology Consortium. Data were available from 13 studies on drinking cessation (9167 cases and 12 593 controls), and from 17 studies on smoking cessation (12 040 cases and 16 884 controls). We estimated the effect of quitting smoking and drinking on the risk of head and neck cancer and its subsites, by calculating odds ratios (ORs) using logistic regression models. Results: Quitting tobacco smoking for 1-4 years resulted in a head and neck cancer risk reduction [OR 0.70, confidence interval (CI) 0.61-0.81 compared with current smoking], with the risk reduction due to smoking cessation after ≥20 years (OR 0.23, CI 0.18-0.31), reaching the level of never smokers. For alcohol use, a beneficial effect on the risk of head and neck cancer was only observed after ≥20 years of quitting (OR 0.60, CI 0.40-0.89 compared with current drinking), reaching the level of never drinkers. Conclusions: Our results support that cessation of tobacco smoking and cessation of alcohol drinking protect against the development of head and neck cancer.

Original language	English (US)
Pages (from-to)	182-196
Number of pages	15
Journal	International journal of epidemiology
Volume	39
Issue number	1
DOIs	https://doi.org/10.1093/ije/dyp291
State	Published - Oct 5 2009

All Science Journal Classification (ASJC) codes

Epidemiology

Access to Document

10.1093/ije/dyp291

Cite this

Marron, M., Boffetta, P., Zhang, Z. F., Zaridze, D., Wünsch-Filho, V., Winn, D. M., Wei, Q., Talamini, R., Szeszenia-Dabrowska, N., Sturgis, E. M., Smith, E., Schwartz, S. M., Rudnai, P., Purdue, M. P., Olshan, A. F., Eluf-Neto, J., Muscat, J., Morgenstern, H., Menezes, A., ... Hashibe, M. (2009). Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. International journal of epidemiology, 39(1), 182-196. https://doi.org/10.1093/ije/dyp291

@article{a5bd0fc46d2f4fe298afabbc8e1351a4,

title = "Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk",

abstract = "Background: Quitting tobacco or alcohol use has been reported to reduce the head and neck cancer risk in previous studies. However, it is unclear how many years must pass following cessation of these habits before the risk is reduced, and whether the risk ultimately declines to the level of never smokers or never drinkers. Methods: We pooled individual-level data from case-control studies in the International Head and Neck Cancer Epidemiology Consortium. Data were available from 13 studies on drinking cessation (9167 cases and 12 593 controls), and from 17 studies on smoking cessation (12 040 cases and 16 884 controls). We estimated the effect of quitting smoking and drinking on the risk of head and neck cancer and its subsites, by calculating odds ratios (ORs) using logistic regression models. Results: Quitting tobacco smoking for 1-4 years resulted in a head and neck cancer risk reduction [OR 0.70, confidence interval (CI) 0.61-0.81 compared with current smoking], with the risk reduction due to smoking cessation after ≥20 years (OR 0.23, CI 0.18-0.31), reaching the level of never smokers. For alcohol use, a beneficial effect on the risk of head and neck cancer was only observed after ≥20 years of quitting (OR 0.60, CI 0.40-0.89 compared with current drinking), reaching the level of never drinkers. Conclusions: Our results support that cessation of tobacco smoking and cessation of alcohol drinking protect against the development of head and neck cancer.",

author = "Manuela Marron and Paolo Boffetta and Zhang, {Zuo Feng} and David Zaridze and Victor W{\"u}nsch-Filho and Winn, {Deborah M.} and Qingyi Wei and Renato Talamini and Neonila Szeszenia-Dabrowska and Sturgis, {Erich M.} and Elaine Smith and Schwartz, {Stephen M.} and Peter Rudnai and Purdue, {Mark P.} and Olshan, {Andrew F.} and Jose Eluf-Neto and Joshua Muscat and Hal Morgenstern and Ana Menezes and Michael McClean and Elena Matos and Mates, {Ioan Nicolae} and Jolanta Lissowska and Fabio Levi and Philip Lazarus and {La Vecchia}, Carlo and Sergio Koifman and Karl Kelsey and Rolando Herrero and Hayes, {Richard B.} and Silvia Franceschi and Leticia Fernandez and Eleonora Fabianova and Daudt, {Alexander W.} and {Dal Maso}, Luigino and Curado, {Maria Paula} and Gabriella Cadoni and Chu Chen and Xavier Castellsague and Stefania Boccia and Simone Benhamou and Gilles Ferro and Julien Berthiller and Paul Brennan and Henrik M{\o}ller and Mia Hashibe",

note = "Funding Information: National Institutes of Health (NIH) US, National Cancer Institute (NCI) [R03 CA113157]. The individual studies were funded by the following grants: Milan study: Italian Association for Research on Cancer (AIRC); Aviano and Italy multicentre studies: Italian Association for Research on Cancer (AIRC), Italian League Against Cancer and Italian Ministry of Research; France study: Swiss League against Cancer [KFS1069-09-2000], Fribourg League against Cancer [FOR381.88], Swiss Cancer Research [AKT 617] and Gustave-Roussy Institute [88D28]; Swiss study: Swiss League against Cancer and the Swiss Research against Cancer/Oncosuisse [KFS-700, OCS-1633]; Central Europe study: World Cancer Research Fund and the European Commission{\textquoteright}s INCO-COPERNICUS Program [Contract No. IC15-CT98-0332]; New York study: National Institutes of Health (NIH) US [P01CA068384 K07CA104231]; Seattle study: National Institutes of Health (NIH) US [R01CA048896, R01DE012609]; Boston study: National Institutes of Health (NIH) US [R01CA078609, R01CA100679]; Iowa study: National Institutes of Health (NIH) US [NIDCR R01DE11979, NIDCR R01DE13110, NIH FIRCA TW01500] and Veterans Affairs Merit Review Funds; North Carolina study: National Institutes of Health (NIH) US [R01CA61188], and in part by a grant from the National Institute of Environmental Health Sciences [P30ES010126]; Tampa study: National Institutes of Health (NIH) US [P01CA068384, K07CA104231, R01DE13158]; Los Angeles study: National Institute of Health (NIH) US [P50CA90388, R01DA11386, R03CA77954, T32CA09142, U01CA96134, R21ES011667] and the Alper Research Program for Environmental Genomics of the UCLA Jonsson Comprehensive Cancer Center; Houston study: National Institutes of Health (NIH) US [R01ES11740, R01CA100264]; Puerto Rico study: jointly funded by National Institutes of Health (NCI) US and NIDCR intramural programs; Latin America study: Fondo para la Investigacion Cientifica y Tecnologica (FONCYT) Argentina, IMIM (Barcelona), Funda¸c{\~a}o de Amparo {\`a} Pesquisa no Estado de S{\~a}o Paulo (FAPESP) [No 01/01768-2], and European Commission [IC18-CT97-0222]; IARC Multicenter study: Fondo de Investigaciones Sanitarias (FIS) of the Spanish Government [FIS 97/ 0024, FIS 97/0662, BAE 01/5013], International Union Against Cancer (UICC), and Yamagiwa-Yoshida Memorial International Cancer Study Grant.",

year = "2009",

month = oct,

day = "5",

doi = "10.1093/ije/dyp291",

language = "English (US)",

volume = "39",

pages = "182--196",

journal = "International journal of epidemiology",

issn = "0300-5771",

publisher = "Oxford University Press",

number = "1",

}

Marron, M, Boffetta, P, Zhang, ZF, Zaridze, D, Wünsch-Filho, V, Winn, DM, Wei, Q, Talamini, R, Szeszenia-Dabrowska, N, Sturgis, EM, Smith, E, Schwartz, SM, Rudnai, P, Purdue, MP, Olshan, AF, Eluf-Neto, J, Muscat, J, Morgenstern, H, Menezes, A, McClean, M, Matos, E, Mates, IN, Lissowska, J, Levi, F, Lazarus, P, La Vecchia, C, Koifman, S, Kelsey, K, Herrero, R, Hayes, RB, Franceschi, S, Fernandez, L, Fabianova, E, Daudt, AW, Dal Maso, L, Curado, MP, Cadoni, G, Chen, C, Castellsague, X, Boccia, S, Benhamou, S, Ferro, G, Berthiller, J, Brennan, P, Møller, H & Hashibe, M 2009, 'Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk', International journal of epidemiology, vol. 39, no. 1, pp. 182-196. https://doi.org/10.1093/ije/dyp291

TY - JOUR

T1 - Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

AU - Marron, Manuela

AU - Boffetta, Paolo

AU - Zhang, Zuo Feng

AU - Zaridze, David

AU - Wünsch-Filho, Victor

AU - Winn, Deborah M.

AU - Wei, Qingyi

AU - Talamini, Renato

AU - Szeszenia-Dabrowska, Neonila

AU - Sturgis, Erich M.

AU - Smith, Elaine

AU - Schwartz, Stephen M.

AU - Rudnai, Peter

AU - Purdue, Mark P.

AU - Olshan, Andrew F.

AU - Eluf-Neto, Jose

AU - Muscat, Joshua

AU - Morgenstern, Hal

AU - Menezes, Ana

AU - McClean, Michael

AU - Matos, Elena

AU - Mates, Ioan Nicolae

AU - Lissowska, Jolanta

AU - Levi, Fabio

AU - Lazarus, Philip

AU - La Vecchia, Carlo

AU - Koifman, Sergio

AU - Kelsey, Karl

AU - Herrero, Rolando

AU - Hayes, Richard B.

AU - Franceschi, Silvia

AU - Fernandez, Leticia

AU - Fabianova, Eleonora

AU - Daudt, Alexander W.

AU - Dal Maso, Luigino

AU - Curado, Maria Paula

AU - Cadoni, Gabriella

AU - Chen, Chu

AU - Castellsague, Xavier

AU - Boccia, Stefania

AU - Benhamou, Simone

AU - Ferro, Gilles

AU - Berthiller, Julien

AU - Brennan, Paul

AU - Møller, Henrik

AU - Hashibe, Mia

N1 - Funding Information: National Institutes of Health (NIH) US, National Cancer Institute (NCI) [R03 CA113157]. The individual studies were funded by the following grants: Milan study: Italian Association for Research on Cancer (AIRC); Aviano and Italy multicentre studies: Italian Association for Research on Cancer (AIRC), Italian League Against Cancer and Italian Ministry of Research; France study: Swiss League against Cancer [KFS1069-09-2000], Fribourg League against Cancer [FOR381.88], Swiss Cancer Research [AKT 617] and Gustave-Roussy Institute [88D28]; Swiss study: Swiss League against Cancer and the Swiss Research against Cancer/Oncosuisse [KFS-700, OCS-1633]; Central Europe study: World Cancer Research Fund and the European Commission’s INCO-COPERNICUS Program [Contract No. IC15-CT98-0332]; New York study: National Institutes of Health (NIH) US [P01CA068384 K07CA104231]; Seattle study: National Institutes of Health (NIH) US [R01CA048896, R01DE012609]; Boston study: National Institutes of Health (NIH) US [R01CA078609, R01CA100679]; Iowa study: National Institutes of Health (NIH) US [NIDCR R01DE11979, NIDCR R01DE13110, NIH FIRCA TW01500] and Veterans Affairs Merit Review Funds; North Carolina study: National Institutes of Health (NIH) US [R01CA61188], and in part by a grant from the National Institute of Environmental Health Sciences [P30ES010126]; Tampa study: National Institutes of Health (NIH) US [P01CA068384, K07CA104231, R01DE13158]; Los Angeles study: National Institute of Health (NIH) US [P50CA90388, R01DA11386, R03CA77954, T32CA09142, U01CA96134, R21ES011667] and the Alper Research Program for Environmental Genomics of the UCLA Jonsson Comprehensive Cancer Center; Houston study: National Institutes of Health (NIH) US [R01ES11740, R01CA100264]; Puerto Rico study: jointly funded by National Institutes of Health (NCI) US and NIDCR intramural programs; Latin America study: Fondo para la Investigacion Cientifica y Tecnologica (FONCYT) Argentina, IMIM (Barcelona), Funda¸cão de Amparo à Pesquisa no Estado de São Paulo (FAPESP) [No 01/01768-2], and European Commission [IC18-CT97-0222]; IARC Multicenter study: Fondo de Investigaciones Sanitarias (FIS) of the Spanish Government [FIS 97/ 0024, FIS 97/0662, BAE 01/5013], International Union Against Cancer (UICC), and Yamagiwa-Yoshida Memorial International Cancer Study Grant.

PY - 2009/10/5

Y1 - 2009/10/5

N2 - Background: Quitting tobacco or alcohol use has been reported to reduce the head and neck cancer risk in previous studies. However, it is unclear how many years must pass following cessation of these habits before the risk is reduced, and whether the risk ultimately declines to the level of never smokers or never drinkers. Methods: We pooled individual-level data from case-control studies in the International Head and Neck Cancer Epidemiology Consortium. Data were available from 13 studies on drinking cessation (9167 cases and 12 593 controls), and from 17 studies on smoking cessation (12 040 cases and 16 884 controls). We estimated the effect of quitting smoking and drinking on the risk of head and neck cancer and its subsites, by calculating odds ratios (ORs) using logistic regression models. Results: Quitting tobacco smoking for 1-4 years resulted in a head and neck cancer risk reduction [OR 0.70, confidence interval (CI) 0.61-0.81 compared with current smoking], with the risk reduction due to smoking cessation after ≥20 years (OR 0.23, CI 0.18-0.31), reaching the level of never smokers. For alcohol use, a beneficial effect on the risk of head and neck cancer was only observed after ≥20 years of quitting (OR 0.60, CI 0.40-0.89 compared with current drinking), reaching the level of never drinkers. Conclusions: Our results support that cessation of tobacco smoking and cessation of alcohol drinking protect against the development of head and neck cancer.

AB - Background: Quitting tobacco or alcohol use has been reported to reduce the head and neck cancer risk in previous studies. However, it is unclear how many years must pass following cessation of these habits before the risk is reduced, and whether the risk ultimately declines to the level of never smokers or never drinkers. Methods: We pooled individual-level data from case-control studies in the International Head and Neck Cancer Epidemiology Consortium. Data were available from 13 studies on drinking cessation (9167 cases and 12 593 controls), and from 17 studies on smoking cessation (12 040 cases and 16 884 controls). We estimated the effect of quitting smoking and drinking on the risk of head and neck cancer and its subsites, by calculating odds ratios (ORs) using logistic regression models. Results: Quitting tobacco smoking for 1-4 years resulted in a head and neck cancer risk reduction [OR 0.70, confidence interval (CI) 0.61-0.81 compared with current smoking], with the risk reduction due to smoking cessation after ≥20 years (OR 0.23, CI 0.18-0.31), reaching the level of never smokers. For alcohol use, a beneficial effect on the risk of head and neck cancer was only observed after ≥20 years of quitting (OR 0.60, CI 0.40-0.89 compared with current drinking), reaching the level of never drinkers. Conclusions: Our results support that cessation of tobacco smoking and cessation of alcohol drinking protect against the development of head and neck cancer.

UR - http://www.scopus.com/inward/record.url?scp=77952310716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952310716&partnerID=8YFLogxK

U2 - 10.1093/ije/dyp291

DO - 10.1093/ije/dyp291

M3 - Article

C2 - 19805488

AN - SCOPUS:77952310716

SN - 0300-5771

VL - 39

SP - 182

EP - 196

JO - International journal of epidemiology

JF - International journal of epidemiology

IS - 1

ER -

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this